Investor FAQs

Show all

IR FAQs

The Conatus stock is traded on the NASDAQ Global Market under the ticker symbol CNAT. The company’s initial public offering (IPO) priced on July 24, 2013.
16745 W. Bernardo Drive, Suite 200
San Diego, CA  92127
Email: info@conatuspharma.com
Phone: 858-376-2600
The company’s fiscal year ends on December 31
Conatus does not expect to declare or pay any cash or other dividends on our common stock.
Conatus does not currently have a direct stock purchase plan.
Quarterly and annual reports, as well as other SEC filings, can be accessed on the Financial Information section of our Investor Relations website or directly from the SEC at www.sec.gov.
You can contact Conatus’s Investor Relations via email at: ir@conatuspharma.com
American Stock Transfer & Trust Company, LLC
6201 15th Avenue
Brooklyn, NY 11219
Phone: 800-937-5449
www.amstock.com